23 completed, 4 unknown, 3 terminated, 1 recruiting. 32 Phase 2, 7 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 32 | Completed 23, Unknown 4, Terminated 3, Recruiting 1, Withdrawn 1 |
| Phase 1 | 7 | Completed 4, Terminated 2, Withdrawn 1 |
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Interferon-gamma: new trials by email Literature Review of Interferon-gamma trials Research Report on Interferon-gamma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized Bayesian Double-blind Controlled Trial Versus Placebo Interferon Gamma 1-b, Placebo - Post-aggressive Immunosuppression, Adult Patients Admitted to Intensive Care With Initial Severity (SOFA of the First 24 Hours Post-admission ≥ 6 | Phase 2 / Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 170 | 2026-02-24 | 2026-11-12 |
| Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR, Avelumab, Pembrolizumab - Other Skin | Phase 1 / Phase 2 | Terminated | Fred Hutchinson Cancer Center | 7 | 2019-07-03 | 2025-03-06 |
| Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma Interferon Gamma-1b, Laboratory Biomarker Analysis, Pembrolizumab - Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 28 | 2017-12-14 | 2023-10-25 |
| Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer Interferon-gamma (IFN-γ), Paclitaxel, Trastuzumab - Breast Cancer, Breast Cancer, Male | Phase 1 / Phase 2 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 51 | 2017-06-23 | 2023-04-19 |
| Open Trail of γIFN for Friedreich Ataxia gamma interferon - Friedreich Ataxia | Phase 2 | Completed | IRCCS Eugenio Medea | 12 | 2016-06-26 | 2020-02-26 |
| A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients gamma interferon - Friedreich Ataxia | Phase 2 | Completed | Azienda Policlinico Umberto I | 10 | 2013-05-01 | 2017-04-21 |
| A Phase II Trial on Treatment of Steroid-refractory Bronchiolitis Obliterans With Interferon Gamma 1b After Allogeneic SCT Interferon gamma 1b - Steroid-refractory Bronchiolitis Obliterans | Phase 2 | Unknown | University Hospital Regensburg | 10 | 2012-07-01 | 2012-07-12 |
| A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B IFN-γ 1b (Actimmune), Adefovir dipivoxil, IFN-γ 1b and Adefovir dipivoxil combination - Hepatitis B | Phase 2 | Unknown | Huntington Medical Research Institutes | 30 | 2008-09-01 | 2010-10-21 |
| Study of Gamma Interfereon in Metastatic Colorectal Carcinoma 5-Fluorouracil, Leucovorin (LV), Gamma-Interferon-1b (IFN-γ) - Colorectal Cancer | Phase 2 | Completed | Accelerated Community Oncology Research Network | 48 | 2006-02-01 | 2012-03-01 |
| Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis Interferon-Gamma - HIV Coinfection, Aids/Hiv Problem | Phase 1 / Phase 2 | Completed | SPP Pharmaclon Ltd. | 78 | 2006-01-19 | 2024-01-25 |
| Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C Peg-interferon alpha 2a (drug), Ribavirin (drug), Interferon gamma (drug) - Hepatitis C, Chronic | Phase 2 | Completed | French National Agency for Research on AIDS and Viral Hepatitis | 65 | 2004-06-01 | 2007-08-30 |
| Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma aldesleukin, filgrastim, recombinant interferon gamma - Lymphoma | Phase 2 / Phase 3 | Completed | Children's Oncology Group | 24 | 2003-11-01 | 2013-10-17 |
| Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections recombinant interferon gamma, voriconazole - Infection, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Completed | National Cancer Institute (NCI) | 2003-08-01 | 2013-06-19 | |
| New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis interferon-gamma, infliximab, dmard - Reactive Arthritis | Phase 2 | Unknown | Charite University, Berlin, Germany | 40 | 2003-01-01 | 2006-09-08 |
| Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer Carboplatin, GM-CSF (Sargramostim), Interferon Gamma - Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Completed | M.D. Anderson Cancer Center | 59 | 2003-01-01 | 2012-08-07 |
| ITV Extension Study recombinant fowlpoxvirus (rFPV) expressing HIV gag-pol antigens, HIV gag-pol antigens and interferon-gamma (IFN-y) - HIV | Phase 1 / Phase 2 | Completed | Kirby Institute | 35 | 2002-09-01 | 2007-02-27 |
| An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF) interferon-gamma 1b - Lung Disease, Pulmonary Fibrosis | Phase 2 | Completed | InterMune | 210 | 2002-09-01 | 2007-11-06 |
| Gamma Interferon Therapy for Chronic Hepatitis C Gamma Interferon 1b - Chronic Hepatitis C | Phase 2 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 20 | 2001-12-01 | 2008-03-04 |
| A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF) Interferon-gamma 1b - Idiopathic Pulmonary Fibrosis | Phase 2 | Completed | InterMune | 32 | 2001-11-01 | 2007-11-06 |
| Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma aldesleukin, idiotype-pulsed autologous dendritic cell vaccine APC8020, recombinant interferon gamma - Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Completed | Mayo Clinic | 15 | 2001-08-01 | 2011-05-16 |
Showing 20 of 32. Sign in to see all of them.
Breast Neoplasms (2) · Colonic Neoplasms (2) · Colorectal Neoplasms (2) · Friedreich Ataxia (2) · Hepatitis C (2) · Hepatitis C, Chronic (2) · Idiopathic Pulmonary Fibrosis (2) · Mesothelioma, Malignant (2) · Mycobacterium Infections (2) · Pneumonia (2) · Tuberculosis, Pulmonary (2) · Acquired Immunodeficiency Syndrome (1) · Arthritis, Reactive (1) · Breast Neoplasms, Male (1) · Bronchiolitis Obliterans (1)
National Institute of Allergy and Infectious Diseases (NIAID) (4) · National Cancer Institute (NCI) (3) · InterMune (2) · Accelerated Community Oncology Research Network (1) · Aga Khan University (1) · Assistance Publique - Hôpitaux de Paris (1) · Azienda Policlinico Umberto I (1) · Charite University, Berlin, Germany (1) · Children's Oncology Group (1) · Columbia University (1) · Fred Hutchinson Cancer Center (1) · French National Agency for Research on AIDS and Viral Hepatitis (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Herbert Irving Comprehensive Cancer Center (1) · Hoag Memorial Hospital Presbyterian (1)
United States (21) · Australia (2) · France (2) · Germany (2) · Canada (1) · Italy (1) · Pakistan (1) · Russia (1)
Allen R. Chen, MD, PhD, MHS (1) · Andrea Martinuzzi, MD (1) · Benjamin Chousterman, Professor (1) · Carlo Casali, MD (1) · Charles L. Wiseman, MD, FACP (1) · David A Cooper, AO DSc MD FRACP FRCPA FRCP (1) · Ernst Holler, Professor MD (1) · Gwen L. Nichols, MD (1) · Javier Szwarcberg, MD (1) · Jeffrey S. Weber, MD, PhD (1) · Joshua Veatch (1) · Lee Schwartzberg, MD (1) · Martha Q. Lacy, MD (1)
PMID 10850352, PMID 12843799, PMID 15940636, PMID 15994231, PMID 16912304, PMID 17030856, PMID 19264351, PMID 2106474, PMID 22755276, PMID 23190183, PMID 2452123, PMID 3129521, PMID 32269142, PMID 35880940, PMID 42715345, PMID 8368765, PMID 8399072
2004 (1), 2023 (1), P01CA225517 (1), P30CA015083 (1), P30CA015704 (1), U01CA154967 (1)